Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Wednesday, October 17, 2007

Jim Cramer's Mad Money Stock Recap Oct. 16th

Align Technology (ALGN): Cramer began his show with a review of a stock that fits into his opinion that vanity plays are good investments. Align makes Invisalign invisible braces. Cramer thinks that the stock will continue to grow, and that it could go up to $38 if his analysis is correct.
Jim then went to the phonelines. The first caller asked about Intuitive Surgical (ISRG), and Cramer said that he would "buy it with abandon" if the stock pulls back. The second caller asked about the laser group LCA Vision (LCAV), and Cramer said that he thinks they are too risky, and that he doesn't trust LCAV at all. Third caller asked about NutriSystem (NTRI), and Cramer said that Herbalife (HLF) is the best stock in that sector.
LKQ (LKQX). Cramer thinks that the stock is a buy because it is the number one supplier in the auto parts market, and he likes that it has a secondary offering, but the stock continued to go up over the offering price. Cramer said this is one of the best tells that he looks for when investing.
After the lightning round Cramer talked about the fact that there is a large market for people with hearing loss, and he thinks that Sonic Innovations (SNCI) is in a position to profit. Cramer thinks that there is some risk when investing in this small company, but he thinks that the stock could go up to $13.
Masimo (MASI) CEO Joe Kiani was on the show. Cramer likes the stock because he thinks it can't be hurt by a lagging economy. Cramer said that this is the type of stock that is not affected by a slowing economy.
Sudden Death: The first caller asked about Home Depot (HD), and Cramer said that he likes Lowe's (LOW) better. The next caller asked about Companhia Vale do Rio Doce (RIO), and Cramer said he likes the stock. The next caller asked about Steve Madden (SHOO), and Cramer said that Phillips-Van Heusen (PVH) is a better stock to own. The last caller asked about Nuance Communications (NUAN), and Cramer said no to the stock.

Labels: , , , , , , ,

Thursday, April 26, 2007

Biggest Stock Gainers Today

Symbol
Name
Last Trade
Change
Volume
Related Info
ALGN
ALIGN TECHNOLOGY I
22.88 12:04PM ET
5.19 (29.34%)
6,045,704

CVNS
COVANSYS CP
33.31 12:04PM ET
6.51 (24.29%)
2,504,680

INOD
INNODATA ISOGEN
3.50 11:55AM ET
0.61 (21.11%)
VDSI
VASCO DATA SECURITY
21.68 12:04PM ET
4.02 (22.76%)
2,577,758

SWKS
SKYWORKS SOLUTIONS
7.37 12:04PM ET
1.21 (19.64%)
7,917,343

AEIS
ADVANCED ENERGY
25.67 12:04PM ET
4.17 (19.40%)
1,257,050
FFIV
F5 NETWORKS INC
78.71 12:04PM ET
12.64 (19.13%)
4,459,850

CNS
COHN & STEERS
54.22 11:59AM ET
9.26 (20.60%)
793,150

HAR
HARMAN INTL INDS
122.49 11:59AM ET
19.93 (19.43%)
4,620,300
GEL
GENESIS ENERGY LP
26.12 11:57AM ET
3.88 (17.45%)
342,600

OI
OWENS ILLINOIS
31.19 11:59AM ET
4.89 (18.59%)
3,782,940
WST
WEST PHARMA SVCS INC
53.82 11:59AM ET
7.56 (16.34%)
747,550

KOG
KODIAK OIL
5.86 11:59AM ET
0.70 (13.57%)
2,471,400
OMTL
OMTOOL LTD
2.05 11:15AM ET
0.29 (16.48%)
10,472
SBCF
SEACOAST BKNG CP
23.57 12:04PM ET
3.14 (15.37%)
392,899

WEN
WENDYS INTL INC
38.11 11:59AM ET
5.43 (16.62%)
8,829,900

PSAI
PEDIATRIC SRVS
15.85 11:59AM ET
2.15 (15.71%)
220,127
RKT
ROCK-TENN CO CL A
40.44 11:59AM ET
4.60 (12.83%)
741,150

CBRX
COLUMBIA LABS INC
2.66 12:04PM ET
0.32 (13.67%)
5,799,659

MTH
MERITAGE HOMES CORP
37.70 11:59AM ET
5.14 (15.79%)
3,060,280

Labels: , , , , , , , , , , , , , , , , , , ,

Monday, February 12, 2007

Biggest Gainers Monday

Adeza Biomedical Corp. (NasdaqGS:ADZA - News) agreed to be bought by Cytyc Corp. (NasdaqGS:CYTC - News) for $24 a share, or approximately $450 million, Cytyc will fund the purchase through existing cash, the cash on Adeza's balance sheet, and existing credit facilities. The deal, which is subject to customary closing conditions and regulatory approvals, is expected to be completed before the end of March. Cytyc said that, excluding one-time costs related to the acquisition, it expects the acquisition to be break-even to earnings in 2007 and at least accretive by 5 cents to 2008 earnings per share.
Adobe Systems (NasdaqGS:ADBE - News) was upgraded to buy from Oppenheimer & Co., which cited valuation.
Align Technology (NasdaqGM:ALGN - News) shares rose after Piper Jaffray upgraded the teeth misalignment treatment company to outperform from market perform, citing evidence of growing demand for its Invisalign product. Analyst Raj Denhoy also raised his stock price target to $21 from $15, his forecast for 2007 revenue from orthodontists to $85 million from $79 million. "Overall, orthodontists expect their use of Invisalign to increase by approximately 13.4% over the next 12 months; we had previously modeled just 10.6%," Denhoy said in a research note.
Apogee Enterprises (NasdaqGS:APOG - News) lifted its outlook for fiscal 2007, saying it now sees earnings of $1.04 to $1.10 a share. Its previous projection was for a profit of 98 cents to $1.04 a share for the year. The average estimate of analysts polled by Thomson Financial is for a profit of $1.01 a share in 2007. The Minneapolis-based glass products maker anticipates it will post revenue growth near the top of its prior range of 12% to 15%. For fiscal 2008, Apogee forecast earnings of $1.20 to $1.30 a share on revenue growth of 8% to 11%. Wall Street's current consensus estimate is for a profit of $1.19 a share in fiscal 2008.
Apple Inc. (NasdaqGS:AAPL - News) was upgraded to buy from hold at Citigroup, which cited several meaningful product catalysts and expectations of significant gross market upside due to declines in flash memory and DRAM (dynamic random access memory) pricing. Analyst Richard Gardner kept his 12-month price target at $105.
Asta Funding (NasdaqGS:ASFI - News) agreed to acquire a portfolio with a face value of $6.9 billion for a purchase price of $300 million. Asta said the portfolio is made up of primarily credit card accounts.
Brush Wellman (NYSE:BW - News) said its fourth-quarter earnings jumped to $30.3 million, or $1.48 a share, from $4.1 million, or 93 cents a share, a year earlier, boosted by a $21.3 million benefit related to the reversal of the company's deferred tax valuation allowance. The Cleveland supplier of metal products and engineered material systems said excluding the allowance, the company earned 44 cents a share. Revenue rose 48% to $207.8 million from $140.6 million a year ago. Analysts surveyed by Thomson Financial expected, on average, earnings of 41 cents a share on revenue of $189 million. Analyst earnings forecasts typically exclude unusual items. In addition, Brush Engineered said it expects 2007 sales to rise 25% to 30%to $950 million to $1 billion, with earnings of $3 to $3.75 a share, including a $1-per-share benefit from the sale of inventory.
Cell Therapeutics (NasdaqGM:CTIC - News) said it plans to form a new company, Aequus BioPharma, Inc., and spin it off. The company didn't provide details of whether the spin-off will be in the form of an initial public offering or a dividend to its shareholders.
Ciena Corp. (NasdaqGS:CIEN - News) was upgraded by Credit Suisse to outperform from neutral, citing the networking company's strong competitive position in the rebounding optical infrastructure market. Analyst Paul Silverstein also lifted his stock price target to $36 from $29.25, his 2007 earnings estimate to 93 cents a share from 91 cents and his 2007 revenue forecast to $715 million from $710 million. The stock was up 2.2% at $28.90 in pre-open trading. "We expect to see further sustained increase in demand due to increasing bandwidth consumption and the concomitant need for network re-architecture driven primarily by increasing amounts of video on service provider and enterprise networks," Silverstein said in a research note.
Digital Music Group (NasdaqGM:DMGI - News) signed a revenue-sharing content agreement with YouTube. The deal calls for certain components of Digital Music's video and music catalog to be made available by YouTube. Financial terms weren't disclosed.
Diversa Corp. (NasdaqGM:DVSA - News) shares gained after the San Diego-based maker of specialty enzymes said it has agreed to merge with privately held Celunol Corp, a developer of technology for producing ethanol from cellulosic biomass feedstocks. Under the terms of the deal, Diversa will issue 15 million shares to acquire the outstanding equity of Celunol. Diversa will also provide Celunol with up to $20 million in debt financing to fund its operations prior to the closing of the transaction. Diversa stockholders will own roughly 76% of the combined company, and Celunol stockholders and option holders will own 24%. The deal is expected to close by the end of the second quarter.
Express Scripts (NasdaqGS:ESRX - News) was upgraded to buy from hold at Jefferies & Co. The firm boosted its price target on the stock to $90 from $77.
Grubb & Ellis Co. (NYSE:GBE - News) said its second-quarter net income rose to $6.1 million, or 23 cents a share, from $4.9 million, or 36 cents, a year earlier. The average earnings estimate of four analysts surveyed by Thomson Financial was 9 cents a share. The Chicago real-estate services company said revenue for the three months ended Dec. 31 rose to $145.8 million from $140.6 million.
Home Depot Inc. (NYSE:HD - News) said its board has decided to evaluate strategic alternatives for its HD Supply business, including a possible sale, spin-off or initial public offering. The Atlanta-based retailer said there can be no assurance that any deal will occur or its timing. Home Depot said it hired Lehman Brothers as its financial advisor and it does not expect to update its progress or disclose developments with respect to the exploration of HD Supply strategic alternatives unless the board of directors has approved a definitive transaction.
Hydril (NasdaqGS:HYDL - News) shares leapt after the manufacturer of pressure control products for oil and gas production agreed to be acquire by Tenaris S.A. for $97 a share in cash. The offer represents a premium of roughly 17% to Hydril's closing share price last Friday. The deal is expected to close in the second quarter. Certain members of the Seaver family have agreed to vote Hydril shares, representing roughly 22% of the combined votes rights, in favor of the merger, Luxembourg-based Tenaris said.
Infineon AG (NYSE:IFX - News) was approached by at least three private equity groups in the last six months, according to a report in the Financial Times newspaper. The firm's management do not want a deal, but some potential bidders remain hopeful a deal could still be possible this year, the newspaper said, citing a person familiar with the situation. If Infineon, which has a market capitalization of 8 billion euros ($10.4 billion), were bought, it would be the largest private equity deal ever in Germany, the FT added.
Kraft Foods (NYSE:KFT - News) was upgraded to neutral from reduce at UBS.
Kronos Inc. (NasdaqGS:KRON - News) was upgraded to strong buy from buy at Needham & Co. The firm lifted its price target on the stock to $50.
Lamson & Sessions (NYSE:LMS - News) said its board hired Perella Weinberg Partners as financial adviser to explore "a range of strategic and financial alternatives" for the company. The Cleveland thermoplastics company said the potential actions include the sale of certain assets or the entire company, formation of joint ventures, a change to the company's capital structure, or a continuation of the company's business plan.
LCA-Vision Inc. (NasdaqGS:LCAV - News) reported fourth-quarter earnings of $7.1 million, or 34 cents a share, up from a year-ago profit of $6.6 million, or 30 cents a share. Revenue jumped 26% in the latest three months to $58.8 million from $46.8 million a year ago. The Cincinnati-based provider of laser vision correction services also said it's increased its quarterly dividend by 50% to 18 cents a share from 12 cents. Looking ahead, LCA-Vision forecast earnings of $2.05 to $2.15 a share for 2007 on revenue growth of 20% to 25%.
Published By Michael Baron of MarketWatch

Labels: , , , , , , , , , , , , , , , , , , ,

Wednesday, January 31, 2007

Biggest Decliners Monday

Acco Brands Corp. (NYSE:ABD - News) was downgraded to neutral from outperform at Credit Suisse.
Align Technology (NasdaqGM:ALGN - News) was downgraded to market perform from outperform at Barrington Research, citing valuation.
Allergan Inc. (NYSE:AGN - News) reported fourth-quarter earnings of $136.8 million, or 89 cents a share, down from a year-ago profit of $140.1 million, or $1.03 a share. On an adjusted basis, excluding certain charges, the company earned $156.5 million, or $1.02 a share, in the latest quarter. The average estimate of analysts polled by Thomson Financial was for a profit of $1.02 a share in the December period. Looking ahead, the Irvine, Calif., medical and healthcare products company said it expects adjusted earnings of $4.27 to $4.31 a share for fiscal 2007 on total product net sales of between $3.46 billion and $3.63 billion. For the first quarter, it sees adjusted earnings of 88 to 90 cents a share on total product net sales of between $830 million and $850 million. Wall Street's current consensus estimates are for earnings of $4.31 a share for the year and 98 cents a share for the March quarter.
Allstate (NYSE:ALL - News) reported a 17% increase in fourth-quarter profit, but the insurer's results missed analyst estimates and the company said it will stop giving profit forecasts.
Buckeye Technologies' (NYSE:BKI - News) said second-quarter net income more than doubled to $3.82 million, or 10 cents a share, from $1.85 million, or 5 cents a share, a year earlier, as the company cut costs. The Memphis cellulose and absorbent products company's sales dropped 1.9% to $184.7 million from $188.3 million. Costs of goods sold fell 4.2% to $155.7 million from $162.5 million. On average, analysts expected the company to post earnings of 11 cents a share and revenue of $199.5 million, according to Thomson Financial.
Calumet Specialty Products (NasdaqGM:CLMT - News) was downgraded to neutral from buy at Goldman Sachs.
Celestica (NYSE:CLS - News) shares fell after the company said its fourth-quarter net loss widened to $60.8 million, or 27 cents a share, from $28.2 million, or 12 cents a share, as costs of sales rose. The most recent quarter's results include a $30 million net charge related to an increase in inventory at a Mexico facility and a $59 million restructuring charge. Excluding amortization of intangible assets, among other items, the Canada-based provider of electronics manufacturing services posted per-share earnings of 3 cents vs. 13 cents in the prior year. Revenue rose 9% to $2.26 billion from $2.08 billion. The company sees an adjusted first-quarter per-share loss of 4 to 15 cents, on revenue of $1.7 billion to $1.9 billion. The company was also downgraded to underperform from peer perform at Bear Stearns.
U.S.-listed shares of Chinese companies fell, tracking steep losses in their home market after a senior legislator said the market may be overheated after a 130% gain in 2006. The comments by Cheng Siwei, vice-chairman of the standing committee of the National People's Congress, in an interview with the Financial Times, raised concerns the Chinese government may take official action to cool speculation after the market hit a record high last week. Chinese ADRs such as Guangshen Railway (NYSE:GSH - News), China Mobile (NYSE:CHL - News), Aluminum Corp. China (NYSE:ACH - News), China Life Insurance (NYSE:LFC - News) and Sinopec (NYSE:SNP - News) were all markedly lower.
Electronics For Imaging's (NasdaqGS:EFII - News) fourth-quarter earnings fell 38% to $7.08 million, or 12 cents a share, from $11.4 million, or 18 cents a share, a year earlier. On a non-GAAP basis, the Foster City, Calif., provider of digital controllers said earnings fell to $22.6 million, or 35 cents a share, from $23.1 million, or 36 cents a share. Revenue rose 5.8% to $153.9 million from $145.4 million in the year-ago period. The company expects to delay its Form 10-K filing for 2006 due to its ongoing stock-option grant investigation. The company sees first-quarter non-GAAP earnings of 25 to 27 cents a share on revenue of $140 million to $143 million.
Haemonetics' (NYSE:HAE - News) shares tumbled after the maker of automated blood processing systems provider forecast earnings of adjusted $2.05 to $2.17 per share for fiscal 2007 with revenue expected to rise between 7% and 9%. The company said this view reflect expectations for continued sales declines in its Japanese business.
Juniper Networks Inc. (NasdaqGS:JNPR - News) reported fourth-quarter revenue rose 4% to $595.8 million, from $575.5 during the same period one year ago. The sales figure slightly topped the estimates of Wall Street analysts surveyed by Thomson Financial, who had forecast $593 million.
Key Tronic (NasdaqGM:KTCC - News) shares dropped after the Spokane, Wash., provider of electronic manufacturing services posted a second-quarter profit of $300,000, or 3 cents a share, down from a profit of $1 million, or 10 cents a share, last year. The latest results include a charge of $940,000 related to a customer unexpectedly declaring bankruptcy in December. Key Tronic also said that new customer programs weren't enough to offset reduced demand from certain existing customers in the latest quarter.
Manitowoc Co. (NYSE:MTW - News) reported fourth-quarter net earnings of $43.9 million, or 69 cents a share, compared with $18.2 million, or 30 cents a share, in the same period last year, on strong revenues in the company's crane segment.
NutriSystem (NasdaqGS:NTRI - News) shares fell after the Horsham, Pa., provider of weight management and fitness products and services forecast first-quarter earnings of 82 to 86 cents a share on revenue of between $200 million and $210 million. Wall Street's current consensus estimate is for a profit of 94 cents a share in March period on revenue of $214 million.
Public Service Enterprise Group (NYSE:PEG - News) said its fourth-quarter earnings from continuing operations fell to $173 million, or 69 cents a share, from $227 million, or 92 cents, a year earlier. The average earnings estimate of seven analysts surveyed by Thomson Financial was 74 cents a share.
Regeneron Pharmaceuticals (NasdaqGM:REGN - News) was initiated with an average rating at Caris & Co.
Published By MarketWatch

Labels: , , , , , , , , , , , , , , , , , , ,

This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed GRB Holding Co., LLC

;